课题基金 / 基金详情

项目摘要

项目成果

CHANDRA MOHAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Lupus is a systemic autoimmune disease that is complex in genetics and its immunological origins. Renal disease is a leading cause of morbidity and mortality in lupus, particularly among minority women. Although serial renal biopsies may be ideal in closely monitoring the progression of lupus nephritis, it may not be practical or feasible. Hence, the long-term goal of these studies is to identify potential biomarkers that may be of use in monitoring the progression of renal disease in lupus. Using different proteomic approaches, we have uncovered several molecules that appear in the urine during antibody-mediated nephritis. Our completed cross-sectional studies have helped uncover 6 potential biomarker candidates in the urine of mice and patients with lupus. In this proposal, we will study a cohort of lupus patients, 90% of whom are minority individuals, in a longitudinal fashion in order to determine if any of the urinary biomarker candidates might be better at predicting flares, severe histological nephritis, or end stage renal disease, compared to currently used laboratory yardsticks. In addition, we propose to establish the specificity of these biomarkers for lupus nephritis, as well as other causes of proteinuria and nephritis. Given the high incidence of end stage renal disease in lupus, early diagnosis and prompt treatment is absolutely essential. Identification of more predictive biomarkers in the urine of these patients could have a profound impact on the clinical management of lupus nephritis. PUBLIC HEALTH RELEVANCE: Given the high incidence of end stage renal disease in minority women with lupus, early diagnosis and prompt treatment is absolutely essential. Identification of surrogate biomarkers in the urine of these patients could have a profound impact on the clinical management of lupus nephritis. Finally, establishing the pathogenic roles of some of these biomarkers, may pave the way towards better therapy for this disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Diagnostic utility of antibodies to post-translationally modified nucleosomes in lupus nephritis
  • 批准号:
    10683684
  • 项目类别:
  • 资助金额:
    $15.83万
  • 财政年份:
    2023
  • 负责人:
    CHANDRA MOHAN
  • 依托单位:
Objective Classification of Lupus Nephritis
  • 批准号:
    10683624
  • 项目类别:
  • 资助金额:
    $66.94万
  • 财政年份:
    2023
  • 负责人:
    CHANDRA MOHAN
  • 依托单位:
Lupus Nephritis Neural Network, LuNN
  • 批准号:
    10246669
  • 项目类别:
  • 资助金额:
    $10.08万
  • 财政年份:
    2020
  • 负责人:
    CHANDRA MOHAN
  • 依托单位:
Monitoring Disease in Lupus
  • 批准号:
    10583454
  • 项目类别:
  • 资助金额:
    $54.2万
  • 财政年份:
    2019
  • 负责人:
    CHANDRA MOHAN
  • 依托单位:
海外基金